Thiourea-Enhanced Flavin Photooxidation
FULL PAPER
CH2), 58.5 (CH3), 68.3 (CH2), 116.8, 130.8 (2CH), 131.4, 133.9, 136.1,
136.2, 146.6, 148.8, 154.9, 159.7, 183.5 ppm (9quaternary C); ES-MS:
m/z (%): 403.1 (100) [M+H]+; HR-MS (EI-MS): calcd for C18H22N6O3S
calcd for C28H25F17N6O6S [M]+
À0.07 ppm).
: 848.1437; found: 848.1438 (delta
C
3,10-BisCAHTRE[UGN 2’-(tert-butyloxycarbonylamino)eth-1’-yl]-7,8-dimethylbenzo[g]-
[M]+ : 402.1474; found: 402.1479 (delta À1.22 ppm).
C
pteridine-2,4-dione (22): Flavin 6-Boc (300 mg, 0.78 mmol, 1 equiv) was
dissolved in dry DMF (40 mL) at 808C. The solution was allowed to cool
to ambient temperature, whereupon potassium carbonate (540 mg,
3.9 mmol, 5 equiv) was added and the mixture was stirred for 30 min. 2-
(tert-Butyloxycarbonylamino)ethyl bromide (520 mg, 2.3 mmol, 3 equiv)
and sodium iodide (180 mg, 1.2 mmol, 1.5 equiv) were then added, and
the reaction mixture was stirred at ambient temperature. After stirring
for 1 d and then again after 2 d, further portions of the bromide (520 mg,
2.3 mmol, 3 equiv each) were added. After 3 d, the reaction mixture was
diluted with chloroform (300 mL), washed with aqueous sodium hydro-
gen carbonate solution (100 mL), water (3100 mL), and brine
(100 mL), and the organic phase was concentrated in vacuo. Compound
22 was isolated by flash chromatography (CHCl3/MeOH 15:1) to yield an
orange solid (210 mg, 52%). Rf =0.34 (CHCl3/MeOH 15:1); m.p. 1368C
(decomp); 1H NMR ([D6]DMSO): d=1.24 (s, 9H; tBu), 1.34 (s, 9H;
tBu), 2.41 (s, 3H; CH3-7), 2.50 (s, 3H; CH3-8), 3.19 (d, J=6.0 Hz, 2H;
CH2-2’), 3.40 (d, J=5.8 Hz, 2H; CH2-2’), 3.96 (t, J=6.0 Hz, 2H; CH2-1’),
4.66 (t, J=5.6 Hz, 2H; CH2-1’), 6.83 (t, J=5.8 Hz, 1H; NH), 7.03 (t, J=
5.8 Hz, 1H; NH), 7.89 (s, 1H; H-9), 7.95 ppm (s, 1H; H-6); 13C NMR
([D6]DMSO): d=18.8, 20.8, 27.9, 28.1 (4CH3), 36.9, 37.8, 40.8, 43.9 (4
CH2), 77.5, 77.8 (2quaternary C), 116.1, 130.9 (2CH), 131.3, 134.0,
135.7, 135.8, 146.5, 148.7, 154.7, 155.6, 155.8, 159.6 ppm (10quaternary
C); ES-MS: m/z (%): 429.2 (25) [M+HÀBoc]+, 473.3 (35) [M+HÀBu]+,
529.3 (100) [M+H]+, 551.4 (40) [M+Na]+.
General Procedure 3 for the preparation of N,N’-substituted flavin–thio-
urea compounds 18–21 and 26–28: The flavin isothiocyanate was dis-
solved in chloroform, and the appropriate amine (2.5 equiv) and TEA
(2 equiv) were added. The reaction mixture was heated to reflux under
TLC control until complete conversion was indicated. The mixture was
then concentrated in vacuo and the crude product was purified by chro-
matography if required.
10-(9’,11’-Diaza-3’,6’,14’-trioxa-10’-thioxopentadec-1’-yl)-7,8-dimethylben-
zo[g]pteridine-2,4-dione (18): Preparation according to GP 3 starting
from 12 (20 mg) yielded 18 as an orange solid (24 mg, 100%). Rf =0.69
(CHCl3/MeOH/AcOH 77.5:15:7.5); m.p. 1788C (decomp); NMR signals
were assigned in analogy to those of the isothiocyanate 12 and with the
help of HMBC and HSQC experiments; 1H NMR (CDCl3): d=2.43 (s,
3H; CH3-7), 2.54 (s, 3H; CH3-8), 3.14–3.72 (m, 15H; CH2-4’, -5’, -7’, -8’,
-12’, -13’), 4.05 (br, 2H; CH2-2’), 4.99 (br, 2H; CH2-1’), 7.59 (s, 1H; H-9),
8.01 ppm (s, 1H; H-6); 13C NMR (100 MHz, CDCl3): d=19.5 (CH3-7),
21.6 (CH3-8), 44.3 (C-4’), 44.9 (C-1’), 58.5 (C-15’), 70.1, 70.3, 70.6, 70.9,
71.5, 71.5 (C-2’, -5’, -7’, -8’, -12’, -13’), 116.0 (C-9), 131.5 (C-9a), 132.6 (C-
6), 135.1 (C-5a), 136.0 (C-4a), 137.3, 148.3 (C-7, -8), 150.5 (C-10a), 156.5,
159.7 (C-2, -4), 183.1 ppm (C=S); ES-MS: m/z (%): 491.3 (100) [M+H]+;
HR-MS (LSI-MS): m/z: calcd for C22H31N6O5S [M+H]+: 491.2077;
found: 491.2086 (delta À1.90 ppm).
10-(3’,5’-Diaza-8’,8’,9’,9’,10’,10’,11’,11’,12’,12’,13’,13’,14’,14’,15’,15’,15’-hep-
tadecafluoro-4’-thioxopentadec-1’-yl)-7,8-dimethylbenzo[g]pteridine-2,4-
dione (19): Preparation according to GP 3 starting from isothiocyanate
10 (50 mg) yielded 19 as a yellowsolid (82 mg, 68%). M.p. 237 8C
(decomp); 1H NMR ([D6]DMSO): d=2.38 (s, 3H; CH3-7), 2.46 (br, 5H;
CH3-8, CH2), 3.50–4.00 (m, 4H; 2CH2), 4.72 (m, 2H; CH2), 7.78 (t, J=
5.4 Hz, 1H; NH), 7.88 (s, 1H; H-9), 8.03 (s, 1H; H-6), 11.37 ppm (s, 1H;
H-3); a 13C NMR spectrum could not be measured to the extremely low
solubility of the title compound; 19F NMR ([D6]DMSO): d=À125.2 (m,
2F), À122.6 (m, 2F), À121.9 (m, 2F), À121.2 (m, 6F), À112.7 (m, 2F),
À79.7 ppm (t, J=9.5 Hz, 3F; CF3); ES-MS: m/z (%): 791.2 (100)
[M+H]+; HR-MS (LSI-MS): m/z: calcd for C25H20F17N6O2S [M+H]+:
791.1097; found: 791.1102 (delta 0.64 ppm).
3,10-Bis(2’-aminoeth-1’-yl)-7,8-dimethylbenzo[g]pteridine-2,4-dione (23):
Flavin 22 (150 mg, 0.29 mmol) was dissolved in methanol (30 mL), and
HCl in diethyl ether (3 mL) was added dropwise. The reaction mixture
was stirred overnight at ambient temperature. It was then concentrated
in vacuo and the yellow-brownish residue was dried to yield 23·2HCl
(114 mg, 100%). Rf =0.00 (CHCl3/MeOH 15:1); m.p. 2688C (decomp);
1H NMR ([D6]DMSO): d=2.42 (s, 3H; CH3-7), 2.55 (s, 3H; CH3-8), 3.07
(d, J=5.5 Hz, 2H; CH2-2’), 3.18 (d, J=5.2 Hz, 2H; CH2-2’), 4.18 (t, J=
5.9 Hz, 2H; CH2-1’), 4.97 (t, J=6.6 Hz, 2H; CH2-1’), 7.97 (s, 1H; H-9),
8.13 (brs, 3H; NH3), 8.30 (s, 1H; H-6), 8.57 ppm (brs, 3H; NH3);
13C NMR ([D6]DMSO): d=18.8, 20.5 (2CH3), 35.8, 37.1, 38.5, 41.2 (4
CH2), 116.3 (CH), 130.5 (quaternary C), 131.2 (CH), 134.2, 136.4, 136.5,
147.6, 149.4, 154.9, 160.0 ppm (7quaternary C); ES-MS: m/z (%): 329.1
(100) [M+H]+.
10-(3’,5’-Diaza-8’,8’,9’,9’,10’,10’,11’,11’,12’,12’,13’,13’,14’,14’,15’,15’,15’-hep-
tadecafluoro-4’-thioxopentadec-1’-yl)-3,7,8-trimethylbenzo[g]pteridine-
2,4-dione (20): Preparation according to GP 3 starting from isothiocya-
nate 11 (15 mg) yielded 28 mg (79%) of 20 as an orange solid; m.p.
2088C (decomp); 1H NMR ([D6]DMSO): d=2.37 (s, 3H; CH3-7), 2.45
(br, 5H; CH3-8, CH2), 3.30 (s, 3H; CH3-3), 3.52–3.98 (m, 4H; 2CH2),
4.69 (m, 2H; CH2), 7.79 (t, J=5.4 Hz, 1H; NH), 7.89 (s, 1H; H-9), 8.05
(s, 1H; H-6); a 13C NMR spectrum could not be measured due to the ex-
tremely lowsolubility of the title compound; 19F NMR (CDCl3): d=
À126.6 (m, 2F), À123.9 (m, 2F), À123.2 (m, 2F), À122.4 (m, 2F), À122.1
(m, 2F), À114.2 (m, 2F), À81.2 (t, J=9.8 Hz, 3F); ES-MS: m/z (%):
805.2 (100) [M+H]+; HR-MS (LSI-MS): m/z: calcd for C26H22F17N6O2S
[M+H]+: 805.1253; found: 805.1281 (delta À3.42 ppm).
3,10-Bis(2’-isothiocyanatoeth-1’-yl)-7,8-dimethylbenzo[g]pteridine-2,4-
dione (24): Preparation according to GP 1 starting from 23·2HCl
(114 mg) yielded 24 as a yellowsolid (95 mg, 81%). Rf =0.35 (CHCl3/
MeOH 25:1); m.p. 1408C (decomp); 1H NMR (CDCl3): d=2.47 (s, 3H;
CH3-7), 2.60 (s, 3H; CH3-8), 3.91 (t, J=6.3 Hz, 2H; CH2-2’), 4.19 (t, J=
5.6 Hz, 2H; CH2-2’), 4.43 (t, J=6.3 Hz, 2H; CH2-1’), 4.99 (t, J=5.9 Hz,
2H; CH2-1’), 7.57 (s, 1H; H-9), 8.10 ppm (s, 1H; H-6); 13C NMR
(CDCl3): d=18.8, 20.9 (2CH3), 40.4, 42.0, 42.3, 43.8 (4CH2), 115.6
(CH), 131.1 (quaternary C), 132.0 (CH), 134.6, 135.0, 137.6, 148.6, 149.4,
155.4, 159.9 ppm (7quaternary C); the signals of the isothiocyanate
groups were not observed, presumably due to a long relaxation time; ES-
MS: m/z (%): 413.1 (100) [M+H]+.
3-(3’,5’-Diaza-8’,8’,9’,9’,10’,10’,11’,11’,12’,12’,13’,13’,14’,14’,15’,15’,15’-hepta-
decafluoro-4’-thioxopentadec-1’-yl)-7,8-dimethyl-10-(3’’-oxabut-1’’-yl)ben-
zo[g]pteridine-2,4-dione (21): Preparation according to GP 3 starting
from isothiocyanate 13 (40 mg) yielded 21 as an orange solid (59 mg,
67%). Rf =0.63 (CH2Cl2/MeOH 10:1); m.p. 1868C (decomp); 1H NMR
(CDCl3): d=2.45 (s, 3H; CH3-7), 2.55 (m, 5H; CH3-8 and CH2-6’), 3.27
(s, 3H; CH3-4’’), 3.65 (m, 2H; CH2-2’), 3.91 (t, J=5.1 Hz, 2H; CH2-1’’),
3.99 (m, 2H; CH2-7’), 4.30 (t, J=6.2 Hz, 2H; CH2-1’), 4.91 (t, J=5.1 Hz,
2H; CH2-2’’), 7.71 (s, 1H; H-9), 8.04 ppm (s, 1H; H-6); 13C NMR
(CDCl3): d=19.6, 21.8 (2CH3), 30.6, 40.6, 40.7, 45.6, 45.7 (5CH2), 59.3
(CH3), 69.5 (CH2), 117.0, 132.1 (2CH), 132.2, 134.9, 135.4, 137.6, 137.6,
148.6, 148.8, 156.5, 160.5 ppm (9quaternary C); 19F NMR (CDCl3): d=
À126.7 (m, 2F), À124.0 (m, 2F), À123.3 (m, 2F), À122.5 (m, 4F), À122.2
(m, 2F), À114.3 (t, J=13.5 Hz, 2F; CF2-8’), À81.3 ppm (t, J=9.8 Hz, 3F;
CF3-16’); ES-MS: m/z (%): 849.3 (100) [M+H]+; HR-MS (EI-MS): m/z:
7,8-Dimethyl-3,10-bis(2’-thioureidoeth-1’-yl)benzo[g]pteridine-2,4-dione
(25): Preparation according to GP 2 starting from isothiocyanate 24
(60 mg) yielded 65 mg (100%) of 25 as an orange-red solid; Rf =0.30
1
(CHCl3/MeOH 10:1); m.p. 2358C (decomp); H NMR ([D6]DMSO): 2.42
(s, 3H; CH3-7), 2.50 (s, 3H; CH3-8), 3.67–3.69 (m, 4H; 2CH2), 4.06 (m,
2H; CH2-2’), 4.76 (m, 2H; CH2-1’), 6.98–7.77 (m, 6H; NH and NH2
groups), 7.95 (s, 1H; H-9), 8.21 ppm (s, 1H; H-6); a 13C NMR spectrum
could not be measured due to the extremely lowsolubility of the title
compound; ES-MS: m/z (%): 447.2 (100) [M+H]+; HR-MS (LSI-MS):
m/z: calcd for C18H23N8O2S2 [M+H]+: 447.1385; found: 447.1372 (delta
À3.00 ppm).
3,10-BisACTHRE[UNG 2’-(3’,5’-diaza-8’,8’,9’,9’,10’,10’,11’,11’,12’,12’,13’,13’,14’,14’,15’,15’,
15’-heptadecafluoro-4’-thioxopentadec-1’-yl)eth-1’-yl]-7,8-dimethylben-
zo[g]pteridine-2,4-dione (26): Preparation according to GP 3 starting
from isothiocyanate 24 (60 mg) yielded a red solid (99 mg, 51%). Rf =
Chem. Eur. J. 2008, 14, 1854 – 1865
ꢁ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1863